Mortality from cancer by place of employment
| Cancer (ICD-9 code) | Chemical manufacturers | Hospitals | All places of employment | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Deaths observed | Deaths expected | SMR | (95% CI) | Deaths observed | Deaths expected | SMR | (95% CI) | Deaths observed | Deaths expected | SMR | (95% CI) | |
| In addition to the cancers listed above, deaths were recorded from cancer of the tongue (1), mouth (1), small intestine (2), larynx (1), pleura (1), thymus (1), cervix (1), body of uterus (1), ovary (2), testis (1), penis (1), and unspecified sites (17). | ||||||||||||
| *Because of changes in disease classification, the earliest follow up for cancer of the liver was from 1958. | ||||||||||||
| Oesophagus (150) | 5 | 4.8 | 1.04 | (0.34 to 2.43) | 3 | 2.3 | 1.32 | (0.27 to 3.84) | 8 | 7.1 | 1.13 | (0.49 to 2.23) |
| Stomach (151) | 5 | 8.0 | 0.62 | (0.20 to 1.46) | 5 | 3.6 | 1.40 | (0.46 to 3.28) | 10 | 11.6 | 0.86 | (0.41 to 1.59) |
| Large intestine (153) | 5 | 7.2 | 0.69 | (0.22 to 1.61) | 5 | 5.6 | 0.90 | (0.29 to 2.09) | 10 | 12.8 | 0.78 | (0.37 to 1.43) |
| Rectum (154) | 2 | 4.6 | 0.43 | (0.05 to 1.56) | 2 | 2.6 | 0.78 | (0.09 to 2.82) | 4 | 7.2 | 0.56 | (0.15 to 1.42) |
| Liver* (155.0, 155.1) | 3 | 1.1 | 2.62 | (0.54 to 7.65) | 0 | 0.6 | 0 | (0 to 6.22) | 3 | 1.7 | 1.72 | (0.36 to 5.04) |
| Pancreas (157) | 8 | 4.7 | 1.72 | (0.74 to 3.38) | 3 | 3.2 | 0.95 | (0.20 to 2.78) | 11 | 7.8 | 1.41 | (0.70 to 2.52) |
| Lung (162) | 43 | 36.5 | 1.18 | (0.85 to 1.59) | 16 | 15.3 | 1.04 | (0.60 to 1.70) | 59 | 51.8 | 1.14 | (0.87 to 1.47) |
| Female breast (174) | – | – | – | – | 11 | 13.1 | 0.84 | (0.42 to 1.51) | 11 | 13.1 | 0.84 | (0.42 to 1.50) |
| Prostate (185) | 5 | 6.9 | 0.72 | (0.23 to 1.68) | 2 | 1.1 | 1.82 | (0.22 to 6.56) | 7 | 8.0 | 0.87 | (0.35 to 1.80) |
| Bladder (188) | 7 | 3.8 | 1.85 | (0.74 to 3.82) | 1 | 1.6 | 0.63 | (0.02 to 3.50) | 8 | 5.4 | 1.49 | (0.64 to 2.94) |
| Kidney (189) | 6 | 2.6 | 2.33 | (0.85 to 5.07) | 1 | 1.2 | 0.81 | (0.02 to 4.50) | 7 | 3.8 | 1.83 | (0.74 to 3.78) |
| Brain and nervous system (191–2) | 1 | 3.4 | 0.30 | (0.01 to 1.65) | 2 | 1.9 | 1.05 | (0.13 to 3.78) | 3 | 5.3 | 0.57 | (0.12 to 1.66) |
| Hodgkin’s disease (201) | 1 | 0.7 | 1.40 | (0.04 to 7.82) | 1 | 0.3 | 2.98 | (0.08 to 16.62) | 2 | 1.0 | 1.91 | (0.23 to 6.89) |
| Non-Hodgkin’s lymphoma (200, 202) | 4 | 2.9 | 1.38 | (0.38 to 3.53) | 3 | 1.9 | 1.59 | (0.33 to 4.66) | 7 | 4.8 | 1.46 | (0.59 to 3.02) |
| Multiple myeloma (203.0) | 3 | 1.5 | 2.03 | (0.42 to 5.94) | 0 | 1.0 | 0 | (0 to 3.57) | 3 | 2.5 | 1.20 | (0.25 to 3.49) |
| Leukaemia (204–8) | 4 | 2.8 | 1.41 | (0.39 to 3.62) | 1 | 1.8 | 0.55 | (0.01 to 3.06) | 5 | 4.6 | 1.08 | (0.35 to 2.51) |